FDA Approved: SCOPOLAMINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for scopolamine filed by Zydus Pharmaceuticals USA Inc., indicating an update to an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness
• Postoperative Nausea and Vomiting

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

SUPPL AP for SCOPOLAMINE (SCOPOLAMINE)